Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ContraFect Corporation stock | $5.34

Own ContraFect Corporation stock in just a few minutes.

Fact checked

ContraFect Corporation is a biotechnology business based in the US. ContraFect Corporation shares (CFRX) are listed on the NASDAQ and all prices are listed in US Dollars. ContraFect Corporation employs 24 staff and has a market cap (total outstanding shares value) of USD$149.3 million.

How to buy shares in ContraFect Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for ContraFect Corporation. Find the stock by name or ticker symbol: CFRX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ContraFect Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$5.34, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ContraFect Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of ContraFect Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

ContraFect Corporation share price

Use our graph to track the performance of CFRX stocks over time.

ContraFect Corporation shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$5.34
52-week rangeUSD$4.45 - USD$13.399
50-day moving average USD$5.4638
200-day moving average USD$5.6578
Wall St. target priceUSD$17.75
PE ratio 18.8
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.44

Buy ContraFect Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Titan
Titan
$0
Stocks, Bonds
N/A
1%
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ContraFect Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ContraFect Corporation price performance over time

Historical closes compared with the close of $5.34 from 2020-12-18

1 week (2021-01-14) 2.89%
1 month (2020-12-22) 0.75%
3 months (2020-10-21) 5.34
6 months (2020-07-21) -17.59%
1 year (2020-01-21) 376.79%
2 years (2019-01-18) 874.45%
3 years (2018-01-19) 376.79%
5 years (2016-01-21) 45.54%

Is ContraFect Corporation under- or over-valued?

Valuing ContraFect Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ContraFect Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ContraFect Corporation's P/E ratio

ContraFect Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, ContraFect Corporation shares trade at around 19x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

ContraFect Corporation financials

Gross profit TTM USD$-1,698,063
Return on assets TTM -48.44%
Return on equity TTM -283.93%
Profit margin 0%
Book value $0.662
Market capitalisation USD$149.3 million

TTM: trailing 12 months

Shorting ContraFect Corporation shares

There are currently 1.7 million ContraFect Corporation shares held short by investors – that's known as ContraFect Corporation's "short interest". This figure is 11.2% up from 1.5 million last month.

There are a few different ways that this level of interest in shorting ContraFect Corporation shares can be evaluated.

ContraFect Corporation's "short interest ratio" (SIR)

ContraFect Corporation's "short interest ratio" (SIR) is the quantity of ContraFect Corporation shares currently shorted divided by the average quantity of ContraFect Corporation shares traded daily (recently around 250977.87610619). ContraFect Corporation's SIR currently stands at 6.78. In other words for every 100,000 ContraFect Corporation shares traded daily on the market, roughly 6780 shares are currently held short.

However ContraFect Corporation's short interest can also be evaluated against the total number of ContraFect Corporation shares, or, against the total number of tradable ContraFect Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ContraFect Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 ContraFect Corporation shares in existence, roughly 60 shares are currently held short) or 0.0691% of the tradable shares (for every 100,000 tradable ContraFect Corporation shares, roughly 69 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against ContraFect Corporation.

Find out more about how you can short ContraFect Corporation stock.

ContraFect Corporation share dividends

We're not expecting ContraFect Corporation to pay a dividend over the next 12 months.

Have ContraFect Corporation's shares ever split?

ContraFect Corporation's shares were split on a 1:10 basis on 4 February 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ContraFect Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for ContraFect Corporation shares which in turn could have impacted ContraFect Corporation's share price.

ContraFect Corporation share price volatility

Over the last 12 months, ContraFect Corporation's shares have ranged in value from as little as $4.45 up to $13.399. A popular way to gauge a stock's volatility is its "beta".

CFRX.US volatility(beta: 1.09)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ContraFect Corporation's is 1.0882. This would suggest that ContraFect Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ContraFect Corporation overview

ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an investigational novel lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staph aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which in preclinical trials for the treatment of pseudomonas aeruginosa infections, including ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. ContraFect Corporation has a collaboration research agreement with The Rockefeller University to identification of novel lysin therapeutic candidates targeting gram-negative pathogens. The company also initiated an expanded access program to provide exebacase for the treatment of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus in COVID-19 patients. ContraFect Corporation was founded in 2008 and is headquartered in Yonkers, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site